The stock has exhibited significant volatility over the past six months, with a notable rally from a low near $76 in early November 2025 to a peak above $86 in late December, followed by a sharp decline in January 2026. Overall, the stock is down 5.5% over the last six months and 12.0% over the last three months, underperforming the broader market which declined 2.8% and 4.6% over the same periods, respectively.

Short-term performance has been weak, with the stock declining 6.5% over the past month, lagging the S&P 500's 5.3% drop. The price action shows a recent recovery from a low of $72.95 on March 27, 2026, to the current price of $75.25, representing a 1.6% gain from the previous close.

The current price of $75.25 sits near the lower end of its 52-week range of $71.25 to $88.07, approximately 15% below the yearly high. The stock's beta of 0.58 indicates it has been less volatile than the market, yet its relative strength metrics show significant underperformance versus the S&P 500 over the past year.

Revenue for Q4 2025 was $6.56 billion, representing an 8.6% year-over-year decline from the same quarter in 2024. Net income for the quarter was $735 million, resulting in a net margin of 11.2%, which is a decrease from the 12.5% margin in Q4 2024. Quarterly profitability has been volatile, with net income swinging from a $3.98 billion loss in Q2 2024 to positive figures in subsequent quarters.

The company maintains a conservative debt profile with a debt-to-equity ratio of 0.22, indicating a strong balance sheet with minimal leverage. Free cash flow over the trailing twelve months is a robust $3.31 billion, providing ample liquidity for shareholder returns and investments.

Return on Equity (ROE) stands at 7.5% and Return on Assets (ROA) at 1.7%, reflecting moderate operational efficiency. The current ratio of 0.85 suggests the company has sufficient short-term assets to cover most of its near-term liabilities.